Organic compounds -- part of the class 532-570 series – Organic compounds – Phosphorus esters
Patent
1988-07-01
1991-03-26
Lone, Werren B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Phosphorus esters
514103, 514970, C07F 902
Patent
active
050030981
ABSTRACT:
A method of reducing or eliminating adverse effects of a pharmaceutical composition or a drug is disclosed. The method comprises administering to an animal or a human an amount of at least one specific isomer of inositol triphosphate sufficient to reduce or eliminate said adverse effects.
REFERENCES:
patent: 2723938 (1955-11-01), Buckwalter
patent: 3591665 (1971-07-01), Kimura et al.
Lim et al., Biochim. Biophys. Acta 302, 316-328 (1973).
Tomlinson et al., Biochemistry, 1, No. 1, 166-171 (1962).
Kerr et al., Arch of Biochem & Biophys, 96, 347-352 (1962).
Suematsu et al., Biochem. & Biophys. Res. Comm., 120, No. 2, 481-485 (1984).
Streb et al., Nature, 306, 67-68 (1983).
Irvine et al., Biochem J., 223, 237-243 (1984).
Blake David
Siren Matti
Argo Margaret
Lone Werren B.
Perstorp AB
LandOfFree
Method of reducing or eliminating adverse effects of a pharmaceu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing or eliminating adverse effects of a pharmaceu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing or eliminating adverse effects of a pharmaceu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618412